296 results on '"Kaitu'u-Lino, Tu'uhevaha"'
Search Results
2. Paternal Expressed Gene 10 (PEG10) is decreased in early-onset preeclampsia
3. Assessment of the tocolytic nifedipine in preclinical primary models of preterm birth
4. Plasma lipids are dysregulated preceding diagnosis of preeclampsia or delivery of a growth restricted infant
5. Using the methylome to predict pre-eclampsia
6. DAAM2 is elevated in the circulation and placenta in pregnancies complicated by fetal growth restriction and is regulated by hypoxia
7. Circulating syndecan-1 is reduced in pregnancies with poor fetal growth and its secretion regulated by matrix metalloproteinases and the mitochondria
8. NR4A2 expression is not altered in placentas from cases of growth restriction or preeclampsia, but is reduced in hypoxic cytotrophoblast
9. The Regulation of Endothelin-1 in Pregnancies Complicated by Gestational Diabetes: Uncovering the Vascular Effects of Insulin
10. MicroRNAs 363 and 149 are differentially expressed in the maternal circulation preceding a diagnosis of preeclampsia
11. Circulating mRNAs are differentially expressed in pregnancies with severe placental insufficiency and at high risk of stillbirth
12. Circulating SPINT1 is a biomarker of pregnancies with poor placental function and fetal growth restriction
13. Circulating GATA2 mRNA is decreased among women destined to develop preeclampsia and may be of endothelial origin
14. EGFR (Epidermal Growth Factor Receptor) Signaling and the Mitochondria Regulate sFlt-1 (Soluble FMS-Like Tyrosine Kinase-1) Secretion
15. Investigating the Effects of Atrial Natriuretic Peptide on the Maternal Endothelium to Determine Potential Implications for Preeclampsia
16. Circulating chemerin is elevated in women with preeclampsia
17. Circulating Chemerin Is Elevated in Women With Preeclampsia
18. Screening circulating proteins to identify biomarkers of fetal macrosomia
19. Repurposing existing drugs as a therapeutic approach for the prevention of preterm birth
20. Placental galectin-3 is reduced in early-onset preeclampsia
21. Serum Collected from Preeclamptic Pregnancies Drives Vasoconstriction of Human Omental Arteries—A Novel Ex Vivo Model of Preeclampsia for Therapeutic Development
22. Placental OLAH Levels Are Altered in Fetal Growth Restriction, Preeclampsia and Models of Placental Dysfunction
23. Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease
24. Associations Between Soluble fms‐Like Tyrosine Kinase‐1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
25. The L-NAME mouse model of preeclampsia and impact to long-term maternal cardiovascular health
26. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta
27. Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks’ gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study
28. Actions of Esomeprazole on the Maternal Vasculature in Lean and Obese Pregnant Mice with Impaired Nitric Oxide Synthesis: A Model of Preeclampsia
29. Transcriptional profiles of genes related to mitochondrial aging in placental pathologies
30. Associations Between Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
31. PSG7 and 9 (Pregnancy-Specific beta-1 Glycoproteins 7 and 9) : Novel Biomarkers for Preeclampsia
32. Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction
33. PSG7 and 9 (Pregnancy‐Specific β‐1 Glycoproteins 7 and 9): Novel Biomarkers for Preeclampsia
34. Circulating SPINT1 Is Reduced in a Preeclamptic Cohort with Co-Existing Fetal Growth Restriction
35. Clinical tools and biomarkers to predict preeclampsia
36. Circulating Growth Differentiation Factor 15 Is Increased Preceding Preeclampsia Diagnosis: Implications as a Disease Biomarker
37. Pre-Clinical Investigation of Cardioprotective Beta-Blockers as a Therapeutic Strategy for Preeclampsia
38. Elevated Circulating and Placental SPINT2 Is Associated with Placental Dysfunction
39. Analysis of mitochondrial regulatory transcripts in publicly available datasets with validation in placentae from pre-term, post-term and fetal growth restriction pregnancies
40. Circulating Growth Differentiation Factor 15 Is Increased Preceding Preeclampsia Diagnosis : Implications as a Disease Biomarker
41. Measuring circulating miRNAs in early pregnancy could identify fetuses’ destined to undergrow and be at increased risk of stillbirth
42. Nanoparticles in pregnancy: the next frontier in reproductive therapeutics
43. Estrogen Is Not Essential for Full Endometrial Restoration after Breakdown: Lessons from a Mouse Model
44. ELABELA/APELA Levels Are Not Decreased in the Maternal Circulation or Placenta among Women with Preeclampsia
45. Therapeutic interventions: The importance of including diseased and healthy samples in preclinical studies
46. A double blind, randomised, placebo-controlled trial to evaluate the efficacy of metformin to treat preterm pre-eclampsia (PI2 Trial): study protocol
47. Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction
48. Nanoparticles in pregnancy: the next frontier in reproductive therapeutics.
49. Circulating SPINT1 is a biomarker of pregnancies with poor placental function and fetal growth restriction.
50. Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.